Zobrazeno 1 - 10
of 620
pro vyhledávání: '"D. Schellinger"'
Autor:
Wendy Dusenbury, Marc D. Malkoff, Peter D. Schellinger, Martin Köhrmann, Adam S. Arthur, Lucas Elijovich, Andrei V. Alexandrov, Georgios Tsivgoulis, Anne W. Alexandrov
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: Prior to the conduct of the Head Position in Stroke Trial (HeadPoST), an international survey ( n = 128) revealed equipoise for selection of head position in acute ischemic stroke. Objectives: We aimed to determine whether equipoise exist
Externí odkaz:
https://doaj.org/article/f61d8e69d0f240febfa4780d48b6cd71
Publikováno v:
Neurological Research and Practice, Vol 4, Iss 1, Pp 1-5 (2022)
Abstract Introduction Based on demographical trends and the expected worldwide increase in the number of individuals with atrial fibrillation, the rate of patients who are on oral anticoagulation therapy for secondary prevention of stroke rises conti
Externí odkaz:
https://doaj.org/article/c53c3356af7e480da06fdf479e2b5975
Autor:
Victor J. Del Brutto, Han‐Christoph Diener, J. Donald Easton, Christopher B. Granger, Lisa Cronin, Eva Kleine, Claudia Grauer, Martina Brueckmann, Kazunori Toyoda, Peter D. Schellinger, Philippe Lyrer, Carlos A. Molina, Aurauma Chutinet, Christopher F. Bladin, Conrado J. Estol, Ralph L. Sacco
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background We sought to determine recurrent stroke predictors among patients with embolic strokes of undetermined source (ESUS). Methods and Results We applied Cox proportional hazards models to identify clinical features associated with recurrent st
Externí odkaz:
https://doaj.org/article/f705003c171c4dc88f66a081ae7c8b99
Autor:
Georgios Tsivgoulis, Aristeidis H. Katsanos, Martin Köhrmann, Valeria Caso, Fabienne Perren, Lina Palaiodimou, Spyridon Deftereos, Sotirios Giannopoulos, John Ellul, Christos Krogias, Dimitris Mavridis, Sokratis Triantafyllou, Anne W. Alexandrov, Peter D. Schellinger, Andrei V. Alexandrov
Publikováno v:
Journal of Stroke, Vol 21, Iss 3, Pp 302-311 (2019)
Background and Purpose Current guidelines do not provide firm directions on atrial fibrillation (AF) screening after ischemic stroke (IS). We sought to investigate the association of implantable cardiac monitoring (ICM) duration with the yield of AF
Externí odkaz:
https://doaj.org/article/705a7b54db6a4a8ea08d97b2a3e9cff1
Publikováno v:
Journal of Stroke, Vol 21, Iss 1, Pp 23-30 (2019)
The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed to show a benefit of closure with an excess
Externí odkaz:
https://doaj.org/article/53a71e66f58c457a8c15d6cc52812ca2
Autor:
Konark Malhotra, Niaz Ahmed, Angeliki Filippatou, Aristeidis H. Katsanos, Nitin Goyal, Konstantinos Tsioufis, Efstathios Manios, Maria Pikilidou, Peter D. Schellinger, Anne W. Alexandrov, Andrei V. Alexandrov, Georgios Tsivgoulis
Publikováno v:
Journal of Stroke, Vol 21, Iss 1, Pp 78-90 (2019)
Background and Purpose Although arbitrary blood pressure (BP) thresholds exist for acute ischemic stroke (AIS) patients eligible for intravenous thrombolysis (IVT), current international recommendations lack clarity on the impact of mean pre- and pos
Externí odkaz:
https://doaj.org/article/f6ac1dd6e6af49de9efe87d9214138ea
Autor:
Georgios Tsivgoulis, Odysseas Kargiotis, Gianmarco De Marchis, Martin Kohrmann, Else Charlotte Sandset, Theodore Karapanayiotides, Diana Aguiar de Sousa, Amrou Sarraj, Apostolos Safouris, Klearchos Psychogios, Konstantinos Vadikolias, Didier Leys, Peter D. Schellinger, Andrei V. Alexandrov
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Intravenous thrombolysis (IVT) represents the only systemic reperfusion therapy able to reverse neurological deficit in patients with acute ischemic stroke (AIS). Despite its effectiveness in patients with or without large vessel occlusion, it can be
Externí odkaz:
https://doaj.org/article/6928148387b8438dac976a102fe46403
Autor:
Aristeidis H. Katsanos, Amrou Sarraj, Michael Froehler, Jan Purrucker, Nitin Goyal, Robert William Regenhardt, Lina Palaiodimou, Nils H. Mueller-Kronast, Robin Lemmens, Peter D. Schellinger, Simona Sacco, Guillaume Turc, Andrei V. Alexandrov, Georgios Tsivgoulis
Publikováno v:
Neurology
Background and ObjectivesThe role of IV thrombolysis (IVT) in patients with large vessel occlusions (LVOs) administered before transfer from a primary stroke center (PSC) to a comprehensive stroke center (CSC) is questioned.MethodsWe included observa
Autor:
Kaori Miwa, Masatoshi Koga, Märit Jensen, Manabu Inoue, Sohei Yoshimura, Mayumi Fukuda-Doi, Florent Boutitie, Henry Ma, Peter A. Ringleb, Ona Wu, Lee H. Schwamm, Steven Warach, Werner Hacke, Stephen M. Davis, Geoffrey A. Donnan, Christian Gerloff, Götz Thomalla, Kazunori Toyoda, Bastian Cheng, Martin Bendszus, Christopher Bladin, Leonid Churilov, Brunce Campbell, Mark Parsons, Nawaf Yassi, Martin Ebinger, Matthias Endres, Jochen B. Fiebach, Timothy Kleinig, Lawrence Latour, Robin Lemmens, Christopher Levi, Didier Leys, Carlos Molina, Keith Muir, Norbert Nighoghossian, Salvador Pedraza, Peter D. Schellinger, Stefan Schwab, Claus Z. Simonsen, Shlee S. Song, Vincent Thijs, Danilo Toni, Chung Y. Hsu, Nils Wahlgren
Publikováno v:
Stroke. 53:3295-3303
Background: Although chronic kidney disease (CKD) is associated with worse stroke outcomes, data regarding the influence of CKD on intravenous thrombolysis outcomes are scarce. We sought to assess the efficacy and safety of intravenous thrombolysis f
Autor:
Julia Krämer, Tanja Krömer-Olbrisch, Heinz-Jürgen Lakomek, Peter D. Schellinger, Dirk Foell, Sven G. Meuth, Vera Straeten
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundAutoimmune adverse events are the most relevant risks of alemtuzumab therapy. We present a patient with relapsing-remitting multiple sclerosis, who developed adult-onset Still’s disease (AOSD) following alemtuzumab treatment.Case Presenta
Externí odkaz:
https://doaj.org/article/57040f27605847888ceccd7757fa9dac